Blackwell Kimberly
Insider CIK 1816465 · ZNTL President & CEO, Director · GLUE Director · IPSC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-06-11 | 2026-06-12 | 25,800 | — | $0 | 25,800 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 74,000 | — | $0 | 74,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-06-13 | 2025-06-16 | 30,700 | — | $0 | 30,700 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 44,000 | — | $0 | 44,000 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 44,000 | — | $0 | 44,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-06-12 | 2024-06-13 | 22,100 | — | $0 | 22,100 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-02-01 | 2024-02-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | F Tax w/h | 2024-02-01 | 2024-02-05 | 20,655 | $11.69 | $241.5K | 484,145 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2024-02-01 | 2024-02-05 | 250,000 | — | $0 | 504,800 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2023-11-13 | 2023-11-13 | 5,000 | $10.29 | $51.4K | 254,800 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2023-06-27 | 2023-06-29 | 44,000 | — | $0 | 44,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-06-14 | 2023-06-15 | 20,500 | — | $0 | 20,500 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2023-02-01 | 2023-02-01 | 355,200 | — | $0 | 355,200 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2023-02-01 | 2023-02-01 | 244,800 | — | $0 | 249,800 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 19,872 | — | $0 | 19,872 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2022-05-16 | 2022-05-20 | 1,708,809 | — | $0 | 1,708,809 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2022-05-16 | 2022-05-20 | 427,202 | — | $0 | 427,202 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise deriv | 2022-01-03 | 2022-01-05 | 1,000 | — | $0 | 38,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise | 2022-01-03 | 2022-01-05 | 1,000 | $47.80 | $47.8K | 6,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-03 | 2022-01-05 | 1,000 | $83.74 | $83.7K | 5,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise deriv | 2021-12-01 | 2021-12-02 | 1,000 | — | $0 | 39,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-01 | 2021-12-02 | 1,000 | $81.84 | $81.8K | 5,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise | 2021-12-01 | 2021-12-02 | 1,000 | $47.80 | $47.8K | 6,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise deriv | 2021-11-01 | 2021-11-02 | 1,000 | — | $0 | 40,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-11-01 | 2021-11-02 | 1,000 | $80.46 | $80.5K | 5,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise | 2021-11-01 | 2021-11-02 | 1,000 | $47.80 | $47.8K | 6,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise deriv | 2021-10-25 | 2021-10-27 | 1,000 | $47.80 | $47.8K | 41,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-10-25 | 2021-10-27 | 1,000 | $77.59 | $77.6K | 5,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | M Exercise | 2021-10-25 | 2021-10-27 | 1,000 | $47.80 | $47.8K | 6,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-06-23 | 2021-06-25 | 47,132 | — | $0 | 47,132 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 19,872 | — | $0 | 19,872 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2021-06-04 | 2021-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2021-06-04 | 2021-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-04-12 | 2021-06-25 | 7,081 | — | $0 | 7,081 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2020-07-01 | 2020-07-01 | 42,000 | — | $0 | 42,000 | SEC↗ |